Lofexidine (sold under the brand names: Britlofex and Kai Er Ding) is an α2A-
adrenergic receptor agonist, historically used as an anti-hypertensive, but more ...
J Subst Abuse Treat. 2001 Jul;21(1):11-7. Lofexidine versus clonidine in rapid
opiate detoxification. Gerra G(1), Zaimovic A, Giusti F, Di Gennaro C, Zambelli U,
The objective of this article was to review the data from recently published trials of
lofexidine in the treatment of opiate withdrawal, with particular attention to ...
Mar 31, 2014 ... Review question. We reviewed the evidence about the effect of alpha2-
adrenergic agonists (clonidine, lofexidine, guanfacine and tizanidine) in ...
Lofexidine tablets are used to replace opiates when the usage of opiods is trying
to be reduced.
Lofexidine (Subutex, Buprenorphine, Britoflex, Naltraxone). Lofexidine
SCIENTIFIC TERM: 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-
Lofexidine is prescribed to reduce the symptoms of withdrawal from opiate
addiction during supervised detoxification. The drug acts on alpha-adrenoceptors
Oct 21, 2007 ... Lofexidine is an alpha2-adrenergic receptor agonist. It can be used as a short
acting anti-hypertensive, but is mostly used to help relieve ...
Apr 12, 2012 ... Lofexidine (Britlofex) is an alpha2-adrenergic receptor agonist commonly used to
alleviate some of the physical symptoms of opiate withdrawal ...
Oct 8, 2015 ... The dosage of lofexidine should be titrated according to the patient's response.
Initial dosage should be 0.8mg per day in divided doses.